Low-molecular-weight EGFR/KDR tyrosine kinase inhibitor offers combinatorial benefit with a rapamycin derivative based on PTEN status

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Rich, J; Shi, Q; Hjelmeland, M; Goudar, R; Keir, S; McLendon, R; Reese, E; Traxler, P; Lane, H; Bigner, D; Friedman, H

Published Date

  • July 1, 2005

Published In

Volume / Issue

  • 7 / 3

Start / End Page

  • 343 - 344

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology

Conference Location

  • Edinburgh, SCOTLAND

Conference Start Date

  • May 5, 2005

Conference End Date

  • May 8, 2005